We are live on ! Find out more
VIM

Vinva Investment Management Portfolio holdings

AUM $8.07B
1-Year Est. Return 29.46%
This Fund
S&P 500
This Quarter Est. Return
+13.57%
1 Year Est. Return
+29.46%
3 Year Est. Return
+116.68%
5 Year Est. Return
10 Year Est. Return
AUM
$1.47B
AUM Growth
+$397M
Cap. Flow
+$247M
Cap. Flow %
16.8%
Top 10 Hldgs %
29.27%
Holding
417
New
62
Increased
255
Reduced
73
Closed
27

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$17.2M
2
AAPL icon
Apple
AAPL
+$14.3M
3
JNJ icon
Johnson & Johnson
JNJ
+$12.9M
4
MSFT icon
Microsoft
MSFT
+$10.9M
5
NVDA icon
NVIDIA
NVDA
+$7.67M

Sector Composition

Rank Sector Weight
1 Technology 31.76%
2 Financials 14.39%
3 Healthcare 12.74%
4 Consumer Discretionary 12.55%
5 Communication Services 7.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INCY icon
301
Incyte
INCY
$24.6B
$696K 0.05%
11,091
-895
-7% -$50.6K
WAB icon
302
Wabtec
WAB
$50.3B
$690K 0.05%
5,433
+161
+3% +$18.2K
EMR icon
303
Emerson Electric
EMR
$91.7B
$686K 0.05%
+7,069
New +$647K
SO icon
304
Southern Company
SO
$106B
$679K 0.05%
9,677
+2,520
+35% +$173K
NDAQ icon
305
Nasdaq
NDAQ
$53.1B
$673K 0.05%
11,553
+2,291
+25% +$121K
RS icon
306
Reliance Steel & Aluminium
RS
$21.7B
$672K 0.05%
2,390
-14,867
-86% -$3.95M
VRSN icon
307
VeriSign
VRSN
$25.7B
$672K 0.05%
3,256
-262
-7% -$54.6K
EL icon
308
Estee Lauder
EL
$32B
$663K 0.05%
4,491
+522
+13% +$69.3K
STNG icon
309
Scorpio Tankers
STNG
$3.81B
$647K 0.04%
+7,295
New +$411K
CPAY icon
310
Corpay
CPAY
$26.6B
$638K 0.04%
+2,260
New +$561K
NBIX icon
311
Neurocrine Biosciences
NBIX
$16B
$634K 0.04%
4,801
+650
+16% +$74.8K
BAH icon
312
Booz Allen Hamilton
BAH
$9.33B
$618K 0.04%
4,862
-792
-14% -$98.7K
LDOS icon
313
Leidos
LDOS
$17.5B
$604K 0.04%
+5,598
New +$570K
MAR icon
314
Marriott International
MAR
$92.7B
$601K 0.04%
2,683
-1,033
-28% -$209K
DVN icon
315
Devon Energy
DVN
$49.5B
$597K 0.04%
+13,050
New +$597K
FCNCA icon
316
First Citizens BancShares
FCNCA
$25.6B
$597K 0.04%
415
+157
+61% +$220K
MKL icon
317
Markel Group
MKL
$22.9B
$593K 0.04%
420
+54
+15% +$76.6K
BRO icon
318
Brown & Brown
BRO
$23.5B
$590K 0.04%
8,322
+2,404
+41% +$172K
VTR icon
319
Ventas
VTR
$45.6B
$583K 0.04%
+11,452
New +$513K
DT icon
320
Dynatrace
DT
$14.3B
$583K 0.04%
10,527
-10,440
-50% -$528K
SNA icon
321
Snap-on
SNA
$21.1B
$575K 0.04%
1,984
-1,174
-37% -$317K
KIM icon
322
Kimco Realty
KIM
$16.2B
$573K 0.04%
26,290
+8,524
+48% +$161K
TDC icon
323
Teradata
TDC
$2.51B
$572K 0.04%
+8,984
New +$404K
INVH icon
324
Invitation Homes
INVH
$17.7B
$563K 0.04%
16,235
-14,867
-48% -$484K
RNG icon
325
RingCentral
RNG
$5.17B
$537K 0.04%
10,616
+2,090
+25% +$62.4K

Similar funds

Vinva Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, Vinva Investment Management held 417 positions worth $1.47B, up 37% from $1.07B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Vinva Investment Management deployed $247M of net new capital in Q4 2023, opening 62 new positions and adding to 255 existing holdings. Its largest new stake was UnitedHealth: 32,283 shares worth $16.9M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Idexx Laboratories, an estimated $4.19M trimmed.

  • Vinva Investment Management's largest Q4 2023 buy was UnitedHealth: 32,283 shares worth $16.9M.
  • Vinva Investment Management added most to Apple in Q4 2023, an estimated $14.3M increase.
  • Vinva Investment Management's biggest Q4 2023 reduction was Idexx Laboratories, cutting an estimated $4.19M.
  • Vinva Investment Management fully exited Clorox in Q4 2023, selling an estimated $3.43M.
  • Vinva Investment Management's ten largest holdings make up 29% of its $1.47B portfolio in Q4 2023.
  • Vinva Investment Management opened 62 new positions and closed 27 in Q4 2023.
  • Vinva Investment Management's portfolio value rose 37% quarter-over-quarter to $1.47B.

Based on Vinva Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.